Who is eligible to apply for SMS Pharmaceuticals rights issue?

Existing shareholders of SMS Pharmaceuticals as of the record date are eligible to participate in a rights issue allowing them to purchase additional shares often at a discount.

How can existing shareholders apply for SMS Pharmaceuticals rights issue?

Shareholders can apply for SMS Pharmaceuticals rights issue by following the company instructions, typically by submitting an application form and making the payment within the specified period.

Is the rights issue of SMS Pharmaceuticals mandatory for existing shareholders?

No! Participation in SMS Pharmaceuticals rights issue is not mandatory, but voluntary. However, shareholders can choose to exercise their rights, sell them, or let them expire.

Has SMS Pharmaceuticals announced any rights issues in the past?

No, SMS Pharmaceuticals hasn’t had any right issues as of {{current_date}} in last 2023-2025

What was the last rights issue price and ratio for SMS Pharmaceuticals?

No, SMS Pharmaceuticals hasn’t had any right issues as of {{current_date}} in last 2023-2025

Sms Pharmaceuticals Ltd. Rights Issue

Sms Pharmaceuticals Ltd. has not split the face value of the share since 29 Aug, 2023

₹511.35₹511.35+25.55 (5.26%)

Last updated on 31 Oct, 2026 | 02:46 IST

Dividends
Splits
Bonus
Rights

Sms Pharmaceuticals . Rights Issue Details

Rights Ratio
No data found

*Disclaimer: The information listed is solely for research purposes and are not recommendations. Please conduct your own research before making any investment decisions.